Global Pharmaceuticals & Biotech Top Stock Picks from Analysts

Daiichi Sankyo Company

Market Cap: JP¥6.7t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

BioMarin Pharmaceutical

Market Cap: US$10.9b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Moderna

Market Cap: US$9.4b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

Haisco Pharmaceutical Group

Market Cap: CN¥65.1b

Researches, develops, manufactures, and sells pharmaceutical products in China.

Corcept Therapeutics

Market Cap: US$7.3b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Revolution Medicines

Market Cap: US$7.3b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

Legend Biotech

Market Cap: US$6.5b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Zealand Pharma

Market Cap: DKK 31.3b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

CRISPR Therapeutics

Market Cap: US$4.8b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Bruker

Market Cap: US$4.5b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

Dong-E-E-JiaoLtd

Market Cap: CN¥31.6b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

Vaxcyte

Market Cap: US$4.2b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

ADMA Biologics

Market Cap: US$4.0b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Arcellx

Market Cap: US$4.0b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Arrowhead Pharmaceuticals

Market Cap: US$3.9b

Develops medicines for the treatment of intractable diseases in the United States.

Metsera

Market Cap: US$3.8b

A clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases.

Soleno Therapeutics

Market Cap: US$3.7b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Akero Therapeutics

Market Cap: US$3.5b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

Zai Lab

Market Cap: US$3.5b

A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.

Crinetics Pharmaceuticals

Market Cap: US$3.2b

A clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Perrigo

Market Cap: US$3.2b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Scholar Rock Holding

Market Cap: US$3.1b

A biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role.

Telix Pharmaceuticals

Market Cap: AU$4.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Ultragenyx Pharmaceutical

Market Cap: US$3.0b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Viking Therapeutics

Market Cap: US$3.0b

A clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.

Immunovant

Market Cap: US$2.8b

A clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

NewAmsterdam Pharma

Market Cap: US$2.8b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Kolon TissueGene

Market Cap: ₩3.5t

Develops cell therapies for orthopedic diseases and other unmet medical needs.

HUTCHMED (China)

Market Cap: UK£1.8b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Alvotech

Market Cap: US$2.5b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Amicus Therapeutics

Market Cap: US$2.5b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.4b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

CG Oncology

Market Cap: US$2.4b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

IDEAYA Biosciences

Market Cap: US$2.3b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

ImmunityBio

Market Cap: US$2.3b

A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.

Apogee Therapeutics

Market Cap: US$2.2b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.